via Curtin University
Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia’s second-leading cause of death.
The study, published in the prestigious PLOS Biology journal and tested on mouse models, identified that a probable cause of Alzheimer’s disease was the leakage from blood into the brain of fat-carrying particles transporting toxic proteins.
Lead investigator Curtin Health Innovation Research Institute (CHIRI) Director Professor John Mamo said his collaborative group of Australian scientists had identified the probable ‘blood-to-brain pathway’ that can lead to Alzheimer’s disease, the most prevalent form of dementia globally.
“While we previously knew that the hallmark feature of people living with Alzheimer’s disease was the progressive accumulation of toxic protein deposits within the brain called beta-amyloid, researchers did not know where the amyloid originated from, or why it deposited in the brain,” Professor Mamo said.
“Our research shows that these toxic protein deposits that form in the brains of people living with Alzheimer’s disease most likely leak into the brain from fat carrying particles in blood, called lipoproteins.
“This ‘blood-to-brain pathway’ is significant because if we can manage the levels in blood of lipoprotein-amyloid and prevent their leakage into the brain, this opens up potential new treatments to prevent Alzheimer’s disease and slow memory loss.”
Building on previous award-winning research that showed beta-amyloid is made outside the brain with lipoproteins, Professor Mamo’s team tested the ground-breaking ‘blood-to-brain pathway’ by genetically engineering mouse models to produce human amyloid-only liver that make lipoproteins.
“As we predicted, the study found that mouse models producing lipoprotein-amyloid in the liver suffered inflammation in the brain, accelerated brain cell death and memory loss,” Professor Mamo said.
“While further studies are now needed, this finding shows the abundance of these toxic protein deposits in the blood could potentially be addressed through a person’s diet and some drugs that could specifically target lipoprotein amyloid, therefore reducing their risk or slowing the progression of Alzheimer’s disease.”
Alzheimer’s WA Chairman Adjunct Professor Warren Harding said the findings may have a significant global impact for the millions of people living with Alzheimer’s disease.
“Having universities like Curtin working with the pharmaceutical industry is important if we are to tackle this devastating disease,” Mr Harding said.
“In Australia, approximately 250 people are diagnosed with dementia daily, adding to the staggering half a million Australians who are already living with dementia. Without significant medical advances like the breakthrough Professor Mamo’s team has made, it is estimated that the number of Australians living with dementia will exceed one million by 2058. This has a significant impact on families, carers and communities.”
Professor Mamo and his research team’s previous research in this area was awarded the NHMRC-Marshall and Warren Award for the most innovative and potentially transformative research.
Currently, the team is conducting a clinical trial, the Probucol in Alzheimer’s-clinical trial, which is based on previous findings that a historic cardiovascular agent lowers lipoprotein-amyloid production and supports cognitive performance in mice. The mouse models used for this research were developed together with Ozgene.
Original Article: New Curtin research identifies likely cause of Alzheimer’s disease
More from: Curtin University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Eisai Submits MAA For Lecanemab As Treatment For Early Alzheimer's Disease In Europeon January 10, 2023 at 4:44 pm
Eisai has submitted a marketing authorization application or MAA for lecanemab (Brand Name in the U.S.: leqembi), an investigational ...
- Blood-based markers may reveal Alzheimer's disease ten years before symptoms showon January 10, 2023 at 4:00 pm
Alzheimer's disease begins decades before the onset of any symptoms, such as memory loss. Consequently, early diagnosis increases the chances of slowing the disease down with drugs. A new study on an ...
- EISAI SUBMITS MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER'S DISEASE IN EUROPEon January 10, 2023 at 3:39 pm
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...
- Eisai files for approval of Alzheimer's drug in Europeon January 10, 2023 at 3:16 pm
Japanese drugmaker Eisai Co Ltd said on Tuesday it had submitted a marketing application to the European health regulator for review of its Alzheimer's drug lecanemab, which was recently granted ...
- FDA approves new Alzheimer's drugon January 10, 2023 at 1:11 pm
It’s people, like her sister dealing with early stages of Alzheimer’s, that are the target of a new drug called Leqembi. “The clinical evidence is seeming to show that it can slow down cognitive ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”Alzheimer’s” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- Dementia Tied to Hearing Losson January 10, 2023 at 2:06 pm
Among 2,413 older adults in the National Health and Aging Trends Study (NHATS), dementia prevalence among people with moderate-to-severe hearing loss was higher than it was among people with normal ...
- New study links hearing loss with dementia in older adultson January 10, 2023 at 1:35 pm
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that older adults with greater severity of hearing loss were more likely to have dementia, but the ...
- Study: Hearing loss linked to dementiaon January 10, 2023 at 12:43 pm
Older adults with greater severity of hearing loss are more likely to have dementia, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Could hearing aids help prevent dementia? New study finds possible linkon January 10, 2023 at 10:11 am
Your hearing could play a role in the risk of developing dementia — and hearing aids could be an important tool in countering that. A new study from researchers at the Johns Hopkins Bloomberg School ...
- Some BP Meds Tied to Significantly Lower Risk for Dementia, Alzheimer'son January 10, 2023 at 9:58 am
Antihypertensive medications that stimulate type 2 and 4 angiotensin II receptors may reduce the rate of dementia compared with those that inhibit these receptors, new research suggests.
Go deeper with Google Headlines on:
[google_news title=”” keyword=”dementia” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]